iDEL Therapeutics is a biotechnology startup developing a drug delivery system that transports therapeutics directly into cancer cells to improve cancer treatment efficacy and reduce side effects.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €9 M | Mar, 2026 | seed |
Industries
Frequently Asked Questions
Where is IDEL Therapeutics located?
IDEL Therapeutics is located in Dortmund, Germany.
What industries does IDEL Therapeutics operate in?
IDEL Therapeutics operates in the following industries: biotechnology, drug delivery, oncology, life sciences.
When was IDEL Therapeutics founded?
IDEL Therapeutics was founded on 2025-09-01.
How much total funding has IDEL Therapeutics raised?
IDEL Therapeutics has raised a total of $9,000,000.
Who are the investors in IDEL Therapeutics?
The investors in IDEL Therapeutics are: BiomedVC, Gründerfonds Ruhr, KHAN Technology Transfer Fund-II, NRW.BANK.
What is the primary mission of IDEL Therapeutics?
IDEL Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies for patients with inflammatory and autoimmune diseases.
Which therapeutic target does IDEL Therapeutics specialize in?
The company specializes in the development of highly selective inhibitors of PI3K delta, a key signaling enzyme involved in the regulation of the immune system.
What makes the drug candidates from IDEL Therapeutics unique?
The drug candidates are designed for high potency and selectivity to maximize therapeutic benefit while reducing the risk of off-target effects and toxicity common in earlier generations of similar treatments.
Are the therapies developed by IDEL Therapeutics currently available for public use?
The company is currently in the clinical-stage of development, which involves rigorous testing in human clinical trials to ensure safety and effectiveness before seeking regulatory approval for public distribution.
What is the goal of the precision medicine approach used by IDEL Therapeutics?
Their precision medicine approach aims to tailor treatments to the specific biological pathways driving a patient's disease, leading to more effective and personalized medical interventions.